Search Results - "Arranz, Eva"

Refine Results
  1. 1
  2. 2
  3. 3

    A Case of Myeloproliferative Neoplasm with BCR-FGFR1 Rearrangement: Favorable Outcome after Haploidentical Allogeneic Transplantation by Arranz, Eva, Herrera, Pilar, López Rubio, Montserrat, Villafuerte-Gutierrez, Paola

    Published in Case reports in hematology (01-01-2018)
    “…Hematopoietic myeloproliferative neoplasms with FGFR1 rearrangement result in the 8p11 myeloproliferative syndrome that in the current Word Health Organization…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Comparison and cost analysis of three protocols for mobilization and apheresis of haematopoietic progenitor cells by López‐Castaño, Francisco, Manresa, Pablo, Díaz, Vanesa, Arranz, Eva, López, Javier, Pérez, María, Alda, Olga, Hernández, Luis

    Published in Journal of clinical apheresis (01-08-2019)
    “…Introduction Autologous bone marrow transplantation is a component of the malignant hemopathy therapy. The preferred mobilization and collection method is…”
    Get full text
    Journal Article
  6. 6

    Identification of novel cytogenetic markers with prognostic significance in a series of 968 patients with primary myelodysplastic syndromes by Sole, F, Luno, E, Sanzo, C, Espinet, B, Sanz, GF, Cervera, J, Calasanz, MJ, Cigudosa, JC, Milla, F, Ribera, JM, Bureo, E, Marquez, ML, Arranz, E, Florensa, L

    Published in Haematologica (Roma) (01-09-2005)
    “…Laboratori de Citogenetica i Biologia Molecular, Hospital del Mar-IMAS, 08003 Barcelona, Spain. fsole@imas.imim.es BACKGROUND AND OBJECTIVES: The main…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Newly acquired chromosome Abnormalities During Course of CLL: a Retrospective Collection Data From 2 Spanish Centers by Loscertales, Javier, Arranz, Eva, Sanz, Maria-Angeles, Burgaleta, Carmen, Gil-Fernández, Juan-José, Steegmann, Juan Luis, Alegre, Adrian

    Published in Blood (20-11-2009)
    “…Abstract 4384 Different recurrent cytogenetic abnormalities have shown clear prognostic value in patients with Chronic Lymphocytic Leukemia (CLL). Acquisition…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14

    Chronic myeloid leukemia patients resistant to or intolerant of interferon alpha and subsequently treated with imatinib show reduced immunoglobulin levels and hypogammaglobulinemia by Steegmann, JL, Moreno, G, Alaez, C, Osorio, S, Granda, A, de la Camara, R, Arranz, E, Reino, FG, Salvanes, FR, Fernandez-Ranada, JM, Munoz, C

    Published in Haematologica (Roma) (01-07-2003)
    “…Department of Hematology, Hospital Universitario de la Princesa, Madrid, Spain. jlsteegmann@wanadoo.es BACKGROUND AND OBJECTIVES: Imatinib mesylate inhibits…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Acute Erythroid Leukemia (AEL): A Clinical, Morphological, Cytogenetic and Follow-Up Study of 69 Patients by Luño, Elisa, Sanzo, Carmen, Sole, Francesc, Gonzalez, Mirian, Granada, Isabel, Espinet, Blanca, Chamorro, Cristina, Collado, Rosa, Cabello, Ana, Calasanz, M. Jose, Arranz, Eva, Bergua, Juan M.

    Published in Blood (16-11-2005)
    “…AEL is a uncommon type of acute leukemia. The subjects in this retrospective study were 69 patients diagnosed as having AEL to assess the incidence of…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19
  20. 20